Clinical Trials Logo

Verruca Vulgaris clinical trials

View clinical trials related to Verruca Vulgaris.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05937672 Recruiting - Clinical trials for Molluscum Contagiosum

Cold Atmospheric Plasma Device Extension Study

Start date: September 18, 2023
Phase: Phase 3
Study type: Interventional

Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.

NCT ID: NCT05799157 Recruiting - Warts Clinical Trials

Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts

Start date: February 28, 2023
Phase: Phase 2
Study type: Interventional

This Phase 2 study has been designed to determine the safety and efficacy of repeated treatment sessions of VDMN-21 patch at two dose strengths as compared to a matched vehicle control patch in subjects with verruca vulgaris

NCT ID: NCT05409365 Recruiting - Healthy Clinical Trials

Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

Start date: May 1, 2022
Phase:
Study type: Observational

This study aims to assess the expression of SCCA2 in the skin of patients with warts and to detect its correlation with characteristics of warts.

NCT ID: NCT04620785 Recruiting - Verruca Vulgaris Clinical Trials

Photodynamic Therapy in Treatment of Verrucae

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

To assess the efficacy (clinically and dermoscopically) and safety of photodynamic therapy using intralesional injection of 4% methylene blue solution as a photosensitizer with IPL versus IPL only in treatment of warts.